Resources from the same session
275MO - Neoadjuvant sacituzumab govitecan, followed by radical cystectomy, for patients with muscle-invasive bladder cancer (MIBC): Updated interim results of SURE-01 trial
Presenter: Brigida Maiorano
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
338MO - Efficacy and safety of tislelizumab (T) combined with gemcitabine and cisplatin (GC) for patients with localized muscle-invasive bladder cancer (MIBC) after radical local surgery: A prospective, phase II study
Presenter: Ming Cao
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
276MO - Epidemiology, treatment (tx) patterns, and clinical outcomes of patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) in Taiwan: A retrospective cohort study
Presenter: Li-Nien Chien
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Genitourinary tumours
Resources:
Webcast